MA

Maruthampara Aboobacker

Active Director Designated Partner DIN 11859322
DIN 11859322 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Maruthampara Aboobacker

Maruthampara Aboobacker is a Designated Partner at Acero Pharma Llp (since 2026).

DIN 11859322
Primary Designation Designated Partner
First Appointment 29 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acero Pharma Llp ADA-6439
Designated Partner29 Jul 20262026Active

Board colleagues of Maruthampara Aboobacker

NameDINCompanyDesignation
Hussain11859320Acero Pharma LlpDesignated Partner
Noushad11859319Acero Pharma LlpDesignated Partner
Kuttikkadan Majeed08802536Acero Pharma LlpDesignated Partner
Muhamed Mustafa Parakkallil11859321Acero Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Acero Pharma Llp
Premium access

Shareholding and investment profile for Maruthampara Aboobacker

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maruthampara Aboobacker

Maruthampara Aboobacker currently holds 1 directorship: Acero Pharma Llp (Designated Partner, since 29 Jul 2026).

Maruthampara Aboobacker was first appointed on 29 Jul 2026 as Designated Partner at Acero Pharma Llp.

The current boards of Maruthampara Aboobacker's companies include Hussain (Acero Pharma Llp), Noushad (Acero Pharma Llp), Kuttikkadan Majeed (Acero Pharma Llp), Muhamed Mustafa Parakkallil (Acero Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available